via Phys.org
As interest in the application of plasma medicine — the use of low-temperature plasma (LTP) created by an electrical discharge to address medical problems — continues to grow, so does the need for research advancements proving its capabilities and potential impacts on the health care industry.
Across the world, many research groups are investigating plasma medicine for applications including cancer treatment and the accelerated healing of chronic wounds, among others.
Researchers from Penn State’s College of Engineering, College of Agricultural Sciences and College of Medicine say direct LTP treatment and plasma-activated media are effective treatments against bacteria found in liquid cultures. The researchers also say they have devised a unique way to create plasma directly in liquids.
The team, comprised of engineers, physicists, veterinary and biomedical scientists and medical professionals, is using an atmospheric-pressure plasma jet to use room temperature — “cold” — plasma to treat bacteria.
Plasma, the fourth state of matter, is typically very hot — thousands to millions of degrees. By using plasma generated at atmospheric pressure or in liquids, the researchers can create molecules and atoms with antibacterial effects without burning anything. Sean Knecht, assistant teaching professor of engineering design at Penn State and leader of the Cross-disciplinary Laboratory for Integrated Plasma Science and Engineering, said this process creates many different types of reactive particles, making the likelihood of bacterial mutations to simultaneously combat all the particles almost nonexistent.
Knecht explained that the team’s research results, published in Scientific Reports, show that plasma technology generates large amounts of reactive oxygen species or reactive particles created from molecules that contain oxygen atoms, including oxygen molecules in the air and water vapor. The plasma’s effect on different bacteria such as E. coli and Staph. aureus is significant, resulting in many bacterial deaths through multiple generations.
“Over the course of four generations of bacteria, these bacteria do not acquire any form of resistance to the plasma treatment,” he said.
Girish Kirimanjeswara, associate professor of veterinary and biomedical sciences at Penn State, said this is extremely important due to the typical way bacteria mutate, making them resistant to antibiotics.
Antibiotics target a specific metabolic pathway, essential protein or nucleic acids in bacteria. Because of this, antibiotics have to enter a bacterial cell to find and bind to that specific target. Any bacterial mutation that decreases an antibiotic’s entry capabilities or increases its rate of exit makes the antibiotic less effective. Mutations happen naturally at a low rate but can rapidly accumulate by selection pressure when introduced to antibiotics aimed at fighting the bacteria.
According to Kirimanjeswara, the team’s research results show that plasma treatment produces various reactive oxygen species at a concentration high enough to kill bacteria, but low enough to not have negative impacts on human cells. He explained that the oxygen species quickly target virtually every part of the bacteria including proteins, lipids and nucleic acids.
“One can call it a sledgehammer approach,” Kirimanjeswara said. “It is difficult to develop resistance by any single mutation or even by a bunch of mutations.”
The team also applied these findings to design a system that can create plasma directly in liquids. The researchers intend to create plasma in blood to address cardiovascular infections directly at the source. To do so, high electric voltage and large electric currents are typically used. In the plasma system created by the researchers, the electrical current and energy that might reach the patient are minimized by using dielectric, or electrically-insulating, materials. Materials that the team would typically use to create the plasma include glass and ceramic due to their capability to withstand high local temperatures. These materials tend to make blood clot and may not be very flexible, a necessity if they are to be used in the cardiovascular system. The team is investigating insulating coatings that are biocompatible, or acceptable by the human body, and flexible. Knecht said the team has identified a polymer called Parylene-C and reported the initial results in the journal IEEE Transactions on Radiation and Plasma Medical Sciences. The team is further pursuing this avenue, as polymers have low melting points and may not withstand repeated exposure to plasma.
“Biocompatible polymers can be used for plasma generation in biological liquids, but their lifetime is limited,” Knecht said. “New unique plasma generation designs must be developed to produce lower intensity plasma discharges that can extend their lifetime. That is what we are continuing to work on.”
Kirimanjeswara said scientists typically work to understand how different bacteria cause disease or how host immune responses eliminate bacteria to create new antibiotics and vaccines. Though these more traditional approaches are essential, they are often gradual and time-consuming. The team’s innovative research highlights the importance of continuing to investigate new ways to combat bacteria.
“Transformative and cross-disciplinary approaches have the potential to speed up finding solutions to urgent global problems,” he said. “It is important for the general public to be aware of and appreciate the fact that the scientific community is engaged in several approaches, some traditional and others nontraditional, to combat the growing problem of antibiotic resistance. We hope our research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infections in the future.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Plasma medicine
- Grifols 2023 Annual Report on Form 20-F filed with the SEC
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on ...
- Non-thermal atmospheric-pressure plasma novel approach to treatment of bone fractures: Study
Break a leg!” is a welcome blessing of good luck, but who wants to hear that they have actually broken a bone? What’s worse, fractures that are displaced or complex require surgery and ...
- Grifols celebrates 50 years in Clayton
Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC. Grifols acquired the Johnston County facility in 2011 ...
- EQS-News: Biotest AG opens 12th plasma collection centre in Germany
EQS-News: Biotest AG / Key word (s): Miscellaneous Biotest AG opens 12th plasma collection centre in Germany 19.04.2024 / 09:00 CET/CEST The issuer is solely responsible for the content of this ...
- Researchers identify patterns that predict ovarian cancer relapse
Using spatial analysis of tissue samples, Cedars-Sinai investigators have identified patterns that could predict whether patients with the most common type of ovarian cancer will experience early ...
Go deeper with Google Headlines on:
Plasma medicine
[google_news title=”” keyword=”plasma medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Cold plasma
- Plasma shows promise in grain decontamination
Glacier FarmMedia - Alberta researchers are harnessing a high-tech concept to decontaminate grain. They’re using cold plasma, which is created by ...
- Making Delaware-in-space history
NASA selects UD's CubeSat spacecraft for upcoming mission ...
- Overcoming the 24-Hour Heart Transplant Time Limit: New Transplant Technique Could Save Lives
Significant advancements in preservation techniques could liberate more hearts for transplantation. More than five decades after the first human-to-human heart transplant, over 5,000 heart transplants ...
- Faster recovery: Irradiated plasma might help bones heal early
Irradiated plasma gives nonunion fractures a healing boost, which improves recovery time. Researchers treated a group of rats with a specific type of plasma called non-thermal atmospheric pressure ...
- Creating an island paradise in a fusion reactor
In their ongoing quest to develop a range of methods for managing plasma so it can be used to generate electricity in a process known as fusion, researchers have shown how two old methods can be ...
Go deeper with Google Headlines on:
Cold plasma
[google_news title=”” keyword=”cold plasma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]